Skip to main content Accessibility help
×
Home

Contents:

Information:

  • Access
  • Cited by 19

Actions:

      • Send article to Kindle

        To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

        Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

        Find out more about the Kindle Personal Document Service.

        The continuous spread of West Nile virus (WNV): seroprevalence in asymptomatic horses
        Available formats
        ×

        Send article to Dropbox

        To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

        The continuous spread of West Nile virus (WNV): seroprevalence in asymptomatic horses
        Available formats
        ×

        Send article to Google Drive

        To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

        The continuous spread of West Nile virus (WNV): seroprevalence in asymptomatic horses
        Available formats
        ×
Export citation

Summary

West Nile virus (WNV) was probably introduced in southern and northern Mexico from the USA in two independent events. Since then, WNV activity has been reported in several Mexican states bordering the USA and the Gulf of Mexico, but disease manifestations seen there in humans and equids are quite different to those observed in the USA. We have analysed WNV seroprevalence in asymptomatic, unvaccinated equids from two Mexican states where no data had been previously recorded. WNV IgG antibodies were detected in 31·6% (91/288) of equine sera from Chiapas and Puebla states (53·3% and 8·0%, respectively). Analysis by plaque reduction neutralization test (PRNT) showed good specificity (99·4%) and sensitivity (84·9%) with the ELISA results. Further analyses to detect antibodies against three different flaviviruses (WNV, St Louis encephalitis virus, Ilheus virus) by haemagglutination inhibition (HI) tests on a subset of 138 samples showed that 53% of the 83 HI-positive samples showed specific reaction to WNV. These data suggest continuous expansion of WNV through Mexico.

West Nile virus (WNV), a flavivirus of the Flaviviridae family [1, 2], was first isolated in Uganda in 1937 [3]. WNV is endemic in Africa, the Middle East and western Asia and, nowadays, also in North America, where it was first reported in 1999 [2, 4]. The virus is responsible for encephalitis outbreaks involving birds, horses and humans, and it has caused over 1000 human deaths in the USA (http://www.cdc.gov). Since 1999, WNV has dispersed widely and it has already been isolated in Central and South America [2, 4, 5]. Its natural transmission cycle is maintained in a cycle between mosquitoes, mainly from the Culex genus, and birds. However, other vertebrates such as humans and horses are incidental hosts, as they do not reach viraemia levels high enough to infect feeding mosquitoes [4].

The first serological evidence of WNV activity in Mexican horses was observed in 2002 in states that border Texas (USA) and the coast of the Gulf of Mexico [68], where migratory birds coming from southeastern USA may have introduced the virus [9]. The first isolation of WNV in Mexico was reported in 2003 in an imported common raven (Corvus corax) from the USA [8]. At the time of sampling for our study, March–April 2006, enzyme-linked immunosorbent assay (ELISA)-positive serology had been already reported in humans, horses and other mammals, reptiles, and different species of birds from several Mexican states [812], but no data from Chiapas or Puebla states had been published. In Mexico, WNV expansion and infectivity behaviour has been quite different from that in the USA [912]. Nevertheless, surveillance of WNV activity is important in order to assess viral expansion, control zoonotic transmission and to elucidate the pathogenic and epidemiological differences observed between the USA and the rest of the world [67, 12].

In this study, we analysed 288 equine sera, including 150 from Pichucalco (17° 30′ N, 93° 07′ W) and Juárez (17° 36′ N, 93° 10′ W) municipalities (Chiapas state), and 138 from Hueytamalco (19° 56′ N, 97° 17′ W), Ayotoxco (20° 05′ N, 97° 24′ W) and S. José Acateno (20° 07′ N, 97° 12′ W) municipalities (Puebla state). These sites have very similar climates, i.e. warm and humid. The temperature ranges from 22°C to 27°C and the average rainfall varies from 2500 to 3000 mm3 per year. All locations are between 120 and 300 m above sea level, except Hueytamalco, located at 914 m. Equine sera comprised 272 (94·4%) horses, 12 (4·2%) mules and four (1·4%) donkeys. The sex distribution was equitable, comprising 149 (51·7%) mares and 139 (48·3%) horses. Twenty-two animals were used for breeding, six for recreational activities and the rest for farm labour. The mean age of the animals was 6·8 years (range 1 month to 25 years). None had been vaccinated or presented with signs of West Nile disease (WND).

Analyses were conducted in bio-safety level-3 containment facilities. Equine sera were stored at −20°C and inactivated at 56°C for 30 min prior to testing. Sera were tested for anti-WNV IgG antibodies by ELISA as described previously [13, 14]. For antigen production, Vero cells were infected with the WNV NY-99 flamingo 382-99 strain. Cell lysates were heat-inactivated and processed as described previously [15]. Uninfected cell lysates, similarly processed, were used as negative controls. The positive cut-off value was assigned using a positive/negative (P/N) ratio ⩾2, calculated by dividing the mean absorbance of the test sera reacted on viral antigen by the absorbance of the negative control serum on viral antigen [16]. Plaque reduction neutralization tests (PRNT) were performed to confirm the ELISA results. The PRNT was conducted on Vero cells with the WNV NY-99 flamingo 382-99 strain using twofold serial sera dilutions, as previously described [16]. Titres were calculated as the reciprocal of the serum dilution, diluted at least 1:40, which reduced plaque formation ⩾90% (PRNT90). Because other flaviviruses circulating in Mexico may cross-react with WNV, a subset of 138 samples was also tested against St Louis encephalitis virus (SLEV) and Ilheus virus (ILHV) by haemagglutination inhibition (HI) tests [16]. A ⩾fourfold antibody titre difference between WNV and the other antigens was used for differential diagnosis.

Our results showed a relatively high seropositivity, 31·6% (91/288) of the samples were IgG-positive for WNV (Table 1). The seroprevalence was higher in Chiapas (53·3%, 80/150; average P/N=3·6, range 2·03–9·8) than in Puebla (8%, 11/138; average P/N=3·6, range 2·5–7·3). No appreciable seroprevalence differences were detected between municipalities within each state. All but one IgG-positive sample from Chiapas were also positive by PRNT (average PRNT90=435, range 40 to ⩾1250) while 15 IgG-negative samples tested positive by PRNT. All ELISA-positive samples from Puebla were also PRNT-positive (average PRNT90=430, range 130 to ⩾1250), and only one case was IgG-negative and PRNT-positive. None of the mules or donkeys from Puebla were positive, while two mules and two donkeys from Chiapas were IgG- and PRNT-positive. Concordance between ELISA and PRNT data was quite good (κ=0·87). Taking the PRNT as the gold standard technique, the sensitivity and specificity of the ELISAs were 84·9% and 99·4%, respectively. Although the seroprevalence was slightly lower in animals aged <2 months (16%), no statistically significant differences were recorded as a consequence of the animals' age or sex.

Table 1. Summary of equine sera tested for evidence of WNV infection by ELISA and PRNT*

WNV, West Nile virus; ELISA, enzyme-linked immunosorbent assay; PRNT, plaque reduction neutralization test.

Data are expressed as number of samples with percentages given in parentheses.

* IgG-positive samples determined by ELISA; virus neutralization positive samples determined by PRNT.

Analysis by HI tests of a subset of 138 (82 IgG- and/or PRNT-positive and 56 negative) samples against three different flaviviruses (WNV, SLEV, ILHV) currently circulating in Central and South America (Table 2) showed that no reactivity was detected in 39·8% (55/138) of them. On the other hand, 44 (31·9%) of the samples were WNV-specific, either because they only contained antibodies against WNV (23/44, 52·3%) or because they presented fourfold higher HI titres against WNV than against SLEV (16/44, 36·4%) or than against both SLEV and ILHV (5/44, 11·3%). The remaining 39 samples (28·3%) recognized flaviviruses, but their specificity could not be clearly established because they showed similarly positive HI titres against WNV and SLEV (24/39, 61·6%) or against WNV, SLEV and ILHV (13/39, 33·3%). Two cases (5·1%) presented low (1/40) HI titres only against SLEV. In summary, 53% (44/83) of the samples that reacted against flaviviruses by HI were specific for WNV.

Table 2. Number of samples that react against WNV, SLEV and ILHV by haemagglutination inhibition tests

WNV, West Nile virus; SLEV, St Louis encephalitis virus; ILHV, Ilheus virus; PRNT, plaque reduction neutralization test.

Data are expressed as number of positive samples/total samples with percentages given in parentheses.

No reactivity by HI against any of the three flaviviruses tested was observed in the only serum that was IgG-positive and did not neutralize the virus, neither was it detected in 54/56 IgG- and PRNT-negative samples (Table 2). The other two samples that were also IgG- and PRNT-negative reacted only against SLEV. Most (61·5%) of the 13 neutralizing sera that were IgG-negative reacted non-specifically against WNV and SLEV, while the other five sera (38·5%) presented specific reactivity against WNV by HI test. Of the 68 samples that were IgG- and PRNT-positive, 42·6% recognized flaviviruses, but their specificity could not be clearly established, while the remaining 57·4% specifically reacted against WNV by HI.

Occasional disparities between ELISA and PRNT results observed in a few sera could be due to several reasons. For example, the neutralizing capability of the 16 IgG-negative samples might be due to the presence of IgM-specific antibodies, which were not tested here because the horses did not have any history of viral encephalitis or other recent illness. All but two of these samples showed low PRNT90 titres against WNV (1/40) and only 38·5% of these samples were specific to WNV when tested by HI (Table 2). On the other hand, the single non-neutralizing IgG-positive sample detected could reflect infection with viruses other than WNV, SLEV and ILHV that were not tested here, but which may cross-react with WNV antibodies.

However, the lower seroprevalence found in Puebla could reflect lower WNV activity, which might be due to a more recent introduction of the virus there. In fact, WNV activity has been previously reported in locations relatively near to the Chiapas municipalities included in our study [58], but distant from the Puebla locations sampled here (Fig. 1). Although altitude, climate and rainfall are quite similar in the municipalities studied, other factors, such as the ecology of mosquitoes, could also play a role in the differences observed.

Fig. 1. Map showing the Mexican locations where West Nile virus activity had been detected prior to the present study [small white symbols (○) and hatched areas] and Puebla and Chiapas municipalities sampled here [circled black symbols (•)].

WNV appears to have been introduced into Mexico in two separate events: carried by birds migrating from southeastern USA to southern Mexico through the Caribbean Sea, and entering from southwestern USA into northern Mexico [9]. Isolation of WNV strains has been unexpectedly difficult in Mexico and the Caribbean [12], we performed several experiments to recover virus upon infection of susceptible cells with samples from this study but all attempts failed. Thus, no genomic analyses of the viral strains circulating in the studied areas could be conducted. However, the geographical location of the Chiapas municipalities sampled here suggests that the WNV activity detected there is probably due to the expansion of strains circulating in the Yucatan peninsula and neighbouring states, while the equidistant situation of the sampled Puebla municipalities from the two areas where WNV was introduced into Mexico makes it difficult to speculate about the origin of the strain colonizing this region.

The relatively high WNV seroprevalence found in Mexican horses in a previous study [8] was initially suggested to be an overestimation due to the neurological disorders of the studied herd; nevertheless our data from asymptomatic, unvaccinated animals support these figures and the apparently lower WNV pathogenicity found in Mexico compared with that observed in the USA. The differences in clinical cases in horses and humans between the USA and Mexico are intriguing [12], particularly the lack of human cases in Mexico, where only seven WNV encephalitis cases have been described [11] (http://portal.salud.gob.mex). This disparity could be due to the wide distribution of other related and potentially cross-protective flaviviruses in the region, such as those analysed here (SLEV and ILHV), because individuals that had previously been in contact with these flaviviruses may have naturally acquired immunity against WNV. In fact, pre-existing immunity to Dengue virus (DENV) infection in humans provides partial protection to subsequent WNV infection [17]; however, this is unlikely to happen in horses because DENV usually does not replicate in non-primate vertebrates and mosquito vectors and reservoir hosts for DENV and WNV are different [18]. In addition, as previously suggested [12], a different virulence of the Mexican WNV strains could also contribute to the paucity of disease there.

The relatively high seropositivity found here in Mexican asymptomatic, unvaccinated horses suggests a continuous expansion of WNV activity throughout the country. Although the clinical consequences of viral infection in birds, horses and humans appear to be different than the worrisome situation in the USA [12], permanent surveillance of WNV activity in horses is important, as they are good sentinel candidates for enzootic viral activity.

ACKNOWLEDGEMENTS

The work was supported in part by grants (AGL2004-06071, AGL2007-61655, FIS-PI071310) from the Spanish Ministerios de Ciencia e Innovación (MICINN) and Sanidad to J.C.S., by grants C01-24 and 2003-025 form the Consejo Nacional de Ciencia y Tecnología, SAGARPA-CONACYT (Mexico) and by contract N01-AI25489 from the National Institutes of Health (U.S.). J.A. was supported by a scholarship from the Spanish MICINN, EER by the ‘Juan de la Cierva’ programme from the MICINN, and L.C. by a scholarship from INIA, Spain.

DECLARATION OF INTEREST

None.

REFERENCES

1. Burke, DS, Monath, TP. Flaviviruses. In: Knipe, DM, Howley, PM, eds. Fields Virology, 4th edn. Philadelphia: Lippincott Williams and Wilkins, 2001, pp. 10431126.
2. Beasley, DWC. Recent advances in the molecular biology of West Nile virus. Current Molecular Medicine 2005; 5:835850.
3. Smithburn, KC, et al. A neurotropic virus isolated from the blood of a native of Uganda. American Journal of Tropical Medicine and Hygiene 1940; 20: 471492.
4. Hayes, EB, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerging Infectious Diseases 2005; 11: 11671173.
5. Morales, MA, et al. West Nile virus isolation from equines in Argentina, 2006. Emerging Infectious Diseases 2006; 12: 15591561.
6. Blitvich, BJ, et al. Serologic evidence of West Nile virus infection in horses, Coahuila State, Mexico. Emerging Infectious Diseases 2003; 9: 853856.
7. Loroño-Pino, MA, et al. Serologic evidence of West Nile virus infection in horses, Yucatan State, Mexico. Emerging Infectious Diseases 2003; 9: 857859.
8. Estrada-Franco, JG, et al. West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerging Infectious Diseases 2003; 9: 16041607.
9. Deardorff, E, et al. Introductions of West Nile virus strains to Mexico. Emerging Infectious Diseases 2006; 12: 314318.
10. Farfán-Ale, JA, et al. Antibodies to West Nile virus in asymptomatic mammals, birds, and reptiles in the Yucatan peninsula of Mexico. American Journal of Tropical Medicine and Hygiene 2006; 74: 908914.
11. Elizondo-Quiroga, D, et al. West Nile virus isolation in human and mosquitoes, Mexico. Emerging Infectious Diseases 2005; 11: 14491452.
12. Blitvich, BJ. Transmission dynamics and changing epidemiology of West Nile virus. Animal Health Research Reviews 2008; 9: 7186.
13. Córdoba, L, et al. Pregnancy increases risk of mortality in West Nile virus-infected mice. Journal of General Virology 2007; 88: 476480.
14. Ebel, GD, et al. Detection of enzyme-linked immunosorbent assay of antibodies to West Nile virus in birds. Emerging Infectious Diseases 2002; 8: 979982.
15. Blitvich, BJ, et al. Epitope-blocking enzyme-linked immunosorbent assay for the detection of serum antibodies to West Nile virus in multiple avian species. Journal of Clinical Microbiology 2003; 41: 10411047.
16. Beaty, BJ, Calisher, CH, and Shope, RE. Arboviruses. In: Schmidt, NJ, Emmons, RW, eds. Diagnostic Procedures for Viral Rickettsial and Chlamydial Infections, 6th edn. Washington: American Public Health Association, 1989, pp. 797855.
17. Tesh, RB, et al. Immunization with heterologous flaviviruses protective against fatal West Nile virus encephalitis. Emerging Infectious Diseases 2002; 8: 245251.
18. Weaver, SC, Barret, AD. Transmission cycles, host range, evolution and emergence of arboviral disease. Nature Reviews Microbiology 2008; 2: 789801.